US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ADC Therapeutics SA

1.25

+0.01501.22%

Volume:210.28K

Turnover:261.02K

Market Cap:123.36M

PE:-0.77

High:1.26

Open:1.25

Low:1.20

Close:1.23

Loading ...

Overview Company News Filings

ADC Therapeutics to Provide Initial Data Update on Lotis-7 Clinical Trial

THOMSON REUTERS

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

BerGenBio ASA (FRA:7BG0) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Leadership ...

ADC Therapeutics Third Quarter 2024 Earnings: EPS Misses Expectations

Simply Wall St.

ADC Therapeutics SA reports results for the quarter ended September 30 - Earnings Summary

ADC Therapeutics Faces Competitive Oncology Market But Analyst Sees 100% Upside - Here's Why

Stephens Starts ADC Therapeutics With Overweight Rating, $6 Price Target

MT Newswires Live

ADC Therapeutics Sa : Guggenheim Cuts Target Price to $10 From $11

THOMSON REUTERS

ADC Therapeutics SA (ADCT) Reports Q3 Loss, Lags Revenue Estimates

ADC Therapeutics Q3 2024 Adj. EPS $(0.28) Beats $(0.40) Estimate, Sales $18.464M Beat $18.462M Estimate

ADC Therapeutics Sa: as of September 30, 2024, Cash and Cash Equivalents Were $274.3 Mln

THOMSON REUTERS

ADC Therapeutics Reports Third Quarter and Year-to-Date 2024 Financial Results and Provides Operational Update

THOMSON REUTERS

ADC Therapeutics Q3 Net Income USD -43.969 Million

THOMSON REUTERS

Press Release: ADC Therapeutics Reports Third Quarter and Year-to-Date 2024 Financial Results and Provides Operational Update

Amicus Therapeutics (FOLD) Q3 Earnings and Revenues Beat Estimates

ADC Therapeutics Announces Investigator-Initiated Study Abstracts Accepted for Presentation at the 66th ASH Annual Meeting

ADC Therapeutics to Present at November Investor Conferences

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

Is ADC Therapeutics (ADCT) Stock Outpacing Its Medical Peers This Year?

ADC Therapeutics to Host Third Quarter 2024 Financial Results Conference Call on November 7, 2024

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ADCT/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ADCT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADCT\",,,,,undefined,":{"symbol":"ADCT","market":"US","secType":"STK","nameCN":"ADC Therapeutics SA","latestPrice":1.245,"timestamp":1745345070296,"preClose":1.23,"halted":0,"volume":210278,"delay":0,"floatShares":73042346,"shares":99083838,"eps":-1.624599,"marketStatus":"Trading","change":0.015,"latestTime":"04-22 14:04:31 EDT","open":1.25,"high":1.26,"low":1.2,"amount":261020.75193059997,"amplitude":0.04878,"askPrice":1.26,"askSize":900,"bidPrice":1.23,"bidSize":1100,"shortable":3,"etf":0,"ttmEps":-1.624599,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745352000000},"marketStatusCode":2,"adr":0,"listingDate":1589515200000,"exchange":"NYSE","adjPreClose":1.23,"preHourTrading":{"tag":"盘前","latestPrice":1.24,"preClose":1.23,"latestTime":"09:26 EDT","volume":100,"amount":124,"timestamp":1745328393631},"postHourTrading":{"tag":"盘后","latestPrice":1.23,"preClose":1.23,"latestTime":"17:34 EDT","volume":1218,"amount":1498.1362,"timestamp":1745271285685},"volumeRatio":1.351236,"impliedVol":3.3329,"impliedVolPercentile":0.992},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADCT\",,,,,undefined,":{"symbol":"ADCT","floatShares":73042346,"roa":"-24.13%","roe":"-705.53%","lyrEps":-1.624599,"volumeRatio":1.351236,"shares":99083838,"dividePrice":0,"high":1.26,"amplitude":0.04878,"preClose":1.23,"low":1.2,"week52Low":1.05,"pbRate":"-0.61","psRate":"1.74","week52High":5.17,"institutionHeld":0,"latestPrice":1.245,"committee":0.1,"eps":-1.624599,"divideRate":0,"volume":210278,"delay":0,"ttmEps":-1.624599,"open":1.25,"prevYearClose":1.99,"prevWeekClose":1.21,"prevMonthClose":1.41,"prevQuarterClose":1.41,"fiveDayClose":1.21,"twentyDayClose":1.65,"sixtyDayClose":1.77},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ADCT\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2489328171","title":"ADC Therapeutics to Provide Initial Data Update on Lotis-7 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2489328171","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489328171?lang=en_us&edition=fundamental","pubTime":"2024-12-06 20:30","pubTimestamp":1733488202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241206:nTUAVKCZK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ADCT","BK4505","BK4139"],"gpt_icon":0},{"id":"2488957379","title":"ADC Therapeutics Makes Grants to New Employees Under Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2488957379","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488957379?lang=en_us&edition=fundamental","pubTime":"2024-12-03 05:30","pubTimestamp":1733175000,"startTime":"0","endTime":"0","summary":"LAUSANNE, Switzerland, Dec. 2, 2024 /PRNewswire/ --ADC Therapeutics SA , a commercial-stage global leader and pioneer in the field of antibody drug conjugates , today announced that the Company has made grants of options to purchase an aggregate of 34,900 of the Company's common shares to three new employees on December 2, 2024 .The Grants were offered as material inducement to the employees' employment. The grants were approved by the Compensation Committee of the Company's Board of Directors pursuant to the Company's Inducement Plan to motivate and reward the recipients to perform at the highest levels and contribute significantly to the success of the Company. The Grants were made in reliance on the employment inducement exemption under the NYSE's Listed Company Manual Rule 303A.08.The Company is issuing this press release pursuant to Rule 303A.08. The Grants shall vest and become exercisable 25% on the first anniversary of the grant date, and 1/48th of the aggregate number of share","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Et0V8U3X6l.Laaek.1Xhrg--~B/aD0yNTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b45d5be0d129d2f2b168ba1839a068c7","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Et0V8U3X6l.Laaek.1Xhrg--~B/aD0yNTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b45d5be0d129d2f2b168ba1839a068c7"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/adc-therapeutics-makes-grants-employees-213000547.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adc-therapeutics-makes-grants-employees-213000547.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4080","LENZ","ADCT","ADC","BK4231","BK4505","BK4139"],"gpt_icon":0},{"id":"2483483948","title":"BerGenBio ASA (FRA:7BG0) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Leadership ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2483483948","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483483948?lang=en_us&edition=fundamental","pubTime":"2024-11-14 15:02","pubTimestamp":1731567762,"startTime":"0","endTime":"0","summary":"Quarterly Revenue: Approximately $40 million, slightly lower due to less sourcing of standard of care.Cash Position: $175 million Norwegian Kroner, projected to fund operations until the third quarter of 2025.For the complete transcript of the earnings call, please refer to the full earnings call transcript.BerGenBio ASA  has identified a significant unmet medical need in STK 11 mutated patients, presenting a substantial market opportunity.The company has received a fast-track designation from the FDA for its treatment, indicating potential for expedited development and review.The company is leading efforts in addressing STK 11 mutated populations with its AXL inhibitor, positioning itself as a pioneer in this niche.The company has faced administrative delays in some study sites, which could impact patient recruitment timelines.The ADC 601 program faced setbacks due to a narrow therapeutic window, leading to its discontinuation by ADC Therapeutics.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/XczF.B0TaxcGYbpx4CABYA--~B/aD01MDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/623896054335b00c0caa5be2a3552da9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/XczF.B0TaxcGYbpx4CABYA--~B/aD01MDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/623896054335b00c0caa5be2a3552da9"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bergenbio-asa-fra-7bg0-q3-070242524.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["FRA","ADCT","ASA"],"gpt_icon":0},{"id":"2482429397","title":"ADC Therapeutics Third Quarter 2024 Earnings: EPS Misses Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2482429397","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482429397?lang=en_us&edition=fundamental","pubTime":"2024-11-09 22:14","pubTimestamp":1731161675,"startTime":"0","endTime":"0","summary":"NYSE:ADCT Earnings and Revenue Growth November 9th 2024. All figures shown in the chart above are for the trailing 12 month  period. Revenue was in line with analyst estimates. Earnings per share  missed analyst estimates by 6.5%.Looking ahead, revenue is forecast to grow 33% p.a. on average during the next 3 years, compared to a 21% growth forecast for the Biotechs industry in the US.The company's share price is broadly unchanged from a week ago.You still need to take note of risks, for example - ADC Therapeutics has   4 warning signs    we think you should know about.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adc-therapeutics-third-quarter-2024-141435334.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ADC","LENZ","ADCT"],"gpt_icon":0},{"id":"2482451486","title":"ADC Therapeutics SA reports results for the quarter ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2482451486","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482451486?lang=en_us&edition=fundamental","pubTime":"2024-11-09 05:48","pubTimestamp":1731102533,"startTime":"0","endTime":"0","summary":"ADC Therapeutics SA reports results for the quarter ended September 30 - Earnings SummaryADC Therapeutics SA ADCT.N reported a quarterly adjusted loss of 42 cents per share for the quarter ended Septe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL8N3MF3X9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADCT"],"gpt_icon":0},{"id":"2482435750","title":"ADC Therapeutics Faces Competitive Oncology Market But Analyst Sees 100% Upside - Here's Why","url":"https://stock-news.laohu8.com/highlight/detail?id=2482435750","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482435750?lang=en_us&edition=fundamental","pubTime":"2024-11-09 02:14","pubTimestamp":1731089653,"startTime":"0","endTime":"0","summary":"Stephens analyst has initiated coverage on ADC Therapeutics SA , a commercial-stage oncology-focused biotechnology company developing antibody-drug conjugates  for patients with hematological malignancies and solid tumors.Also Read:ADC Therapeutics Pulls Plug On Mid-Stage Zynlonta Study In Untreated Lymphoma Patients After Patient Deaths. The analyst points out that Zynlonta has faced stiff competition, and while it reached an annualized revenue run rate of about $80 million at its peak in the first quarter of 2023, it has struggled in the market.The analyst expects Zynlonta’s peak revenue in the third-line treatment setting to reach $110 million in the U.S. by 2032.The analyst’s outlook depends on the expectation that Zynlonta will receive approval for use in second-line treatment for diffuse large B-cell lymphoma , based on positive results from the LOTIS-5 and LOTIS-7 clinical trials.Stephens has initiated with an Overweight rating, with a price target of $6.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/O7IsrG5ipm3KshsRVGYoug--~B/aD01NTM7dz05ODM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/8e04756773113f27726211e72e534912","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/O7IsrG5ipm3KshsRVGYoug--~B/aD01NTM7dz05ODM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/8e04756773113f27726211e72e534912"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adc-therapeutics-faces-competitive-oncology-181413239.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ADCT","LU0006306889.USD","ADC","BK4127","LU0971096721.USD","BK4516","LU1162221912.USD","BK4139","LU0106261372.USD","BK4534","LU1074936037.SGD","LENZ","BK4231","BK4505","LU1668664300.SGD","LU1363072403.SGD","IE00BZ1G4Q59.USD","BK4504","LU1989772923.USD","IE00BKVL7J92.USD","LU0106831901.USD","LU1989772840.SGD","BK4588","BK4585","BK4581","LU0267386448.USD","PBD","LU0225283273.USD","LU0098860793.USD","LU1720051108.HKD","LU0314104364.USD","LU0320765646.SGD","LU1548497426.USD","LU1720051017.SGD","LU2357305700.SGD","BK4080"],"gpt_icon":1},{"id":"2481059041","title":"Stephens Starts ADC Therapeutics With Overweight Rating, $6 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2481059041","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481059041?lang=en_us&edition=fundamental","pubTime":"2024-11-08 21:54","pubTimestamp":1731074059,"startTime":"0","endTime":"0","summary":"Stephens Starts ADC Therapeutics With Overweight Rating, $6 Price Target","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","ADC","ADCT"],"gpt_icon":0},{"id":"2481317134","title":"ADC Therapeutics Sa :  Guggenheim Cuts Target Price to $10 From $11","url":"https://stock-news.laohu8.com/highlight/detail?id=2481317134","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481317134?lang=en_us&edition=fundamental","pubTime":"2024-11-08 20:27","pubTimestamp":1731068857,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nFWN3MF1YL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ADCT","BK4505","BK4139"],"gpt_icon":0},{"id":"2481674511","title":"ADC Therapeutics SA (ADCT) Reports Q3 Loss, Lags Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2481674511","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481674511?lang=en_us&edition=fundamental","pubTime":"2024-11-07 21:50","pubTimestamp":1730987404,"startTime":"0","endTime":"0","summary":"ADC Therapeutics SA  came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to loss of $0.58 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -16.67%. A quarter ago, it was expected that this company would post a loss of $0.44 per share when it actually produced a loss of $0.38, delivering a surprise of 13.64%.Over the last four quarters, the company has surpassed consensus EPS estimates just once.ADC Therapeutics , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $18.46 million for the quarter ended September 2024, missing the Zacks Consensus Estimate by 1.56%. This compares to year-ago revenues of $14.49 million. The company has topped consensus revenue estimates just once over the last four quarters.Investors should be mindful of the fact that the outlook for the industry can have a material impact ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/UYup8AGIrn99rMsHiTllqA--~B/aD04NzY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/d0d4ab152198da2f423d92da8a7d22ee","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/UYup8AGIrn99rMsHiTllqA--~B/aD04NzY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/d0d4ab152198da2f423d92da8a7d22ee"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adc-therapeutics-sa-adct-reports-135004086.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ADC","ADCT"],"gpt_icon":0},{"id":"2481906350","title":"ADC Therapeutics Q3 2024 Adj. EPS $(0.28) Beats $(0.40) Estimate, Sales $18.464M Beat $18.462M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2481906350","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481906350?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:33","pubTimestamp":1730982825,"startTime":"0","endTime":"0","summary":"ADC Therapeutics (NYSE:ADCT) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.40) by 30 percent.  The company reported quarterly sales of $18.464 million which beat the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41804198/adc-therapeutics-q3-2024-adj-eps-0-28-beats-0-40-estimate-sales-18-464m-beat-18-462m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC","LENZ","ADCT"],"gpt_icon":0},{"id":"2481906847","title":"ADC Therapeutics Sa: as of September 30, 2024, Cash and Cash Equivalents Were $274.3 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2481906847","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481906847?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:30","pubTimestamp":1730982609,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nTUA27WZRK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ADCT","BK4505","BK4139"],"gpt_icon":0},{"id":"2481905798","title":"ADC Therapeutics Reports Third Quarter and Year-to-Date 2024 Financial Results and Provides Operational Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2481905798","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481905798?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:30","pubTimestamp":1730982609,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nTUA27WZRK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4505","ADCT"],"gpt_icon":0},{"id":"2481905765","title":"ADC Therapeutics Q3 Net Income USD -43.969 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2481905765","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481905765?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:30","pubTimestamp":1730982608,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nPLX569516:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BK4139","ADCT"],"gpt_icon":0},{"id":"2481063489","title":"Press Release: ADC Therapeutics Reports Third Quarter and Year-to-Date 2024 Financial Results and Provides Operational Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2481063489","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481063489?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:30","pubTimestamp":1730982600,"startTime":"0","endTime":"0","summary":"ADC Therapeutics Reports Third Quarter and Year-to-Date 2024 Financial Results and Provides Operational Update. LOTIS-5 full enrollment and LOTIS-7 initial efficacy, safety update anticipated by end of 2024. Updated ZYNLONTA Phase 2 IIT data in indolent lymphomas to be presented at the 66 American Society of Hematology Annual Meeting in December 2024. Discontinuing ADCT-601 program and prioritizing exatecan-based platform for solid tumors. \"We are excited about the advancements in our ZYNLONTA trials in earlier lines of diffuse large B-cell lymphoma therapy and look forward to reporting more on the combination with glofitamab in our LOTIS-7 trial, as well as reaching the expected full enrollment in LOTIS-5 before year-end,\" said Ameet Mallik, Chief Executive Officer of ADC Therapeutics. \"We are discontinuing ADCT-601 targeting AXL and will prioritize our exatecan-based platform for solid tumors moving forward. With our expected cash runway into mid-2026, we believe we are well position","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADCT","ADC","BK4080","BK4505","BK4231","R","BK4232","BK4139","BK4022","LENZ"],"gpt_icon":0},{"id":"2481683981","title":"Amicus Therapeutics (FOLD) Q3 Earnings and Revenues Beat Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2481683981","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481683981?lang=en_us&edition=fundamental","pubTime":"2024-11-06 21:25","pubTimestamp":1730899506,"startTime":"0","endTime":"0","summary":"Amicus Therapeutics  came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.08 per share. This compares to loss of $0.07 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 25%. A quarter ago, it was expected that this pharmaceutical company would post earnings of $0.03 per share when it actually produced earnings of $0.06, delivering a surprise of 100%.Amicus Therapeutics , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $141.52 million for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 5.68%. This compares to year-ago revenues of $103.5 million. The company has topped consensus revenue estimates two times over the last four quarters.Amicus Therapeutics shares have lost about 17.3% since the beginning of the year versus the S&P 500's gain of 21.2%.While Amicus Therapeutics has underperformed the m","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/CorpxfcSD3xaruoFanouDg--~B/aD00NzY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ace7df31c7fcb10255abe7c990ea373a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/CorpxfcSD3xaruoFanouDg--~B/aD00NzY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ace7df31c7fcb10255abe7c990ea373a"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amicus-therapeutics-fold-q3-earnings-132506979.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ADCT","FOLD"],"gpt_icon":0},{"id":"2481685389","title":"ADC Therapeutics Announces Investigator-Initiated Study Abstracts Accepted for Presentation at the 66th ASH Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2481685389","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481685389?lang=en_us&edition=fundamental","pubTime":"2024-11-05 22:47","pubTimestamp":1730818020,"startTime":"0","endTime":"0","summary":"Oral presentation of investigator-initiated Phase 2 study evaluating ZYNLONTA  in combination with rituximab in patients with r/r follicular lymphoma. Poster presentation of first interim futility analysis of ongoing investigator-initiated Phase 2 clinical trial studying ZYNLONTA as treatment for r/r marginal zone lymphoma. LAUSANNE, Switzerland, Nov. 5, 2024 /PRNewswire/ -- ADC Therapeutics SA , a commercial-stage global leader and pioneer in the field of antibody drug conjugates , today announced independent, investigator-initiated studyabstracts on ZYNLONTA have been accepted for presentation at the 66thAmerican Society of Hematology  Annual Meeting, which will be held inSan Diego, California from December 7-10, 2024.\"Data from the abstract on the Phase 2 study of ZYNLONTA combined with rituximab in patients with high-risk relapsed or refractory follicular lymphoma demonstrated a robust response among the 35evaluable patients, with an overall response rate at week 12 of 97.1%,\"said ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Et0V8U3X6l.Laaek.1Xhrg--~B/aD0yNTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b45d5be0d129d2f2b168ba1839a068c7","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Et0V8U3X6l.Laaek.1Xhrg--~B/aD0yNTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b45d5be0d129d2f2b168ba1839a068c7"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/adc-therapeutics-announces-investigator-initiated-144700069.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adc-therapeutics-announces-investigator-initiated-144700069.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ADCT","BK4231","ADC","ASH","BK4109","BK4505","BK4080","LENZ","LU2463526074.USD"],"gpt_icon":0},{"id":"2480751304","title":"ADC Therapeutics to Present at November Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2480751304","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480751304?lang=en_us&edition=fundamental","pubTime":"2024-11-04 20:15","pubTimestamp":1730722500,"startTime":"0","endTime":"0","summary":"LAUSANNE, Switzerland, Nov. 4, 2024 /PRNewswire/ --ADC Therapeutics SA , a commercial-stage global leader and pioneer in the field of antibody drug conjugates , today announced participation in two investor conferences in November:. Date: November 11, 2024Presentation Time: 11:00 a.m. ETFormat: Fireside ChatSpeaker: Ameet Mallik, Chief Executive Officer. ADC Therapeutics  is a commercial-stage global leader and pioneer in the field of antibody drug conjugates . The Company is advancing its proprietary ADC technology to transform the treatment paradigm for patients with hematologic malignancies and solid tumors.ADC Therapeutics' CD19-directed ADC ZYNLONTA  received accelerated approval by the FDA and conditional approval from the European Commission for the treatment of relapsed or refractory diffuse large B-cell lymphoma after two or more lines of systemic therapy. ZYNLONTA is also in development in combination with other agents and in earlier lines of therapy. In addition to ZYNLONTA,","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Et0V8U3X6l.Laaek.1Xhrg--~B/aD0yNTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b45d5be0d129d2f2b168ba1839a068c7","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Et0V8U3X6l.Laaek.1Xhrg--~B/aD0yNTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b45d5be0d129d2f2b168ba1839a068c7"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/adc-therapeutics-present-november-investor-121500473.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adc-therapeutics-present-november-investor-121500473.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4080","ADCT","LENZ","BK4139","BK4505","BK4231","ADC"],"gpt_icon":0},{"id":"2480852702","title":"ADC Therapeutics Makes Grants to New Employees Under Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2480852702","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480852702?lang=en_us&edition=fundamental","pubTime":"2024-11-02 04:05","pubTimestamp":1730491500,"startTime":"0","endTime":"0","summary":"LAUSANNE, Switzerland, Nov. 1, 2024 /PRNewswire/ --ADC Therapeutics SA , a commercial-stage global leader and pioneer in the field of antibody drug conjugates , today announced that the Company has made grants of options to purchase an aggregate of 42,000 of the Company's common shares to two new employees on November 1, 2024 .The Grants were offered as material inducement to the employees' employment. The grants were approved by the Compensation Committee of the Company's Board of Directors pursuant to the Company's Inducement Plan to motivate and reward the recipients to perform at the highest levels and contribute significantly to the success of the Company. The Grants were made in reliance on the employment inducement exemption under the NYSE's Listed Company Manual Rule 303A.08.The Company is issuing this press release pursuant to Rule 303A.08. The Grants shall vest and become exercisable 25% on the first anniversary of the grant date, and 1/48th of the aggregate number of shares ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Et0V8U3X6l.Laaek.1Xhrg--~B/aD0yNTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b45d5be0d129d2f2b168ba1839a068c7","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Et0V8U3X6l.Laaek.1Xhrg--~B/aD0yNTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b45d5be0d129d2f2b168ba1839a068c7"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/adc-therapeutics-makes-grants-employees-200500133.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adc-therapeutics-makes-grants-employees-200500133.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LENZ","ADC","BK4231","BK4505","ADCT","BK4080","BK4139"],"gpt_icon":0},{"id":"2480836930","title":"Is ADC Therapeutics (ADCT) Stock Outpacing Its Medical Peers This Year?","url":"https://stock-news.laohu8.com/highlight/detail?id=2480836930","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480836930?lang=en_us&edition=fundamental","pubTime":"2024-11-01 21:40","pubTimestamp":1730468411,"startTime":"0","endTime":"0","summary":"The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is ADC Therapeutics SA  one of those stocks right now?A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.ADC Therapeutics SA is a member of the Medical sector. This group includes 1024 individual stocks and currently holds a Zacks Sector Rank of #3. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. ADC Therapeutics SA is currently sporting a Zacks Rank of #2 .Agios Pharmaceuticals  is an","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/T44Iwg7RbRrkaTIYz_liyQ--~B/aD00Njk7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/737ffb82e07dc8bffb77e72d153c91f2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/T44Iwg7RbRrkaTIYz_liyQ--~B/aD00Njk7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/737ffb82e07dc8bffb77e72d153c91f2"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adc-therapeutics-adct-stock-outpacing-134011268.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4231","AGIO","ADC","BK4080","BK4139","ADCT","BK4505"],"gpt_icon":0},{"id":"2479026107","title":"ADC Therapeutics to Host Third Quarter 2024 Financial Results Conference Call on November 7, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2479026107","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479026107?lang=en_us&edition=fundamental","pubTime":"2024-10-31 19:15","pubTimestamp":1730373300,"startTime":"0","endTime":"0","summary":"LAUSANNE, Switzerland, Oct. 31, 2024 /PRNewswire/ -- ADC Therapeutics SA , a commercial-stage global leader and pioneer in the field of antibody drug conjugates , today announced that it will host a conference call and live webcast on Thursday, November 7, 2024, at 8:30 a.m. EST to report financial results for the third quarter 2024 and provide operational updates.ADC Therapeutics  is a commercial-stage global leader and pioneer in the field of antibody drug conjugates . The Company is advancing its proprietary ADC technology to transform the treatment paradigm for patients with hematologic malignancies and solid tumors.ADC Therapeutics' CD19-directed ADC ZYNLONTA  received accelerated approval by the FDA and conditional approval from the European Commission for the treatment of relapsed or refractory diffuse large B-cell lymphoma after two or more lines of systemic therapy. ZYNLONTA is also in development in combination with other agents and in earlier lines of therapy. In addition to","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Et0V8U3X6l.Laaek.1Xhrg--~B/aD0yNTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b45d5be0d129d2f2b168ba1839a068c7","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Et0V8U3X6l.Laaek.1Xhrg--~B/aD0yNTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b45d5be0d129d2f2b168ba1839a068c7"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/adc-therapeutics-host-third-quarter-111500921.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adc-therapeutics-host-third-quarter-111500921.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","LENZ","BK4080","BK4231","BK4139","ADC","BK4505","BK4218","HST","BK4181","ADCT","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":61,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ADCT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-27","symbol":"ADCT","fiscalQuarterEnding":"2024/12","expectedEps":-0.35,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"pre","actualEps":-0.29},{"market":"US","date":"2024-11-07","symbol":"ADCT","fiscalQuarterEnding":"2024/09","expectedEps":-0.36,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.42},{"market":"US","date":"2024-08-06","symbol":"ADCT","fiscalQuarterEnding":"2024/06","expectedEps":-0.44,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722916800000,"reportTimeType":"pre","actualEps":-0.38},{"market":"US","date":"2024-05-06","symbol":"ADCT","fiscalQuarterEnding":"2024/03","expectedEps":-0.56,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1714968000000,"reportTimeType":"pre","actualEps":-0.56},{"market":"US","date":"2024-03-13","symbol":"ADCT","fiscalQuarterEnding":"2023/12","expectedEps":-0.47,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1710302400000,"reportTimeType":"pre","actualEps":-1.03}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ADCT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ADCT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":6,"updateTime":1731211200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ADCT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ADCT","date":"2025-04-21","current":-0.759547,"percent":0.888704,"low":-30.997833,"twenty":-9.524667,"median":-2.325798,"eighty":-0.984197,"high":-0.211833,"avg":-5.269159,"sd":6.153823,"marketCap":119891443},"quantilePoints":[{"date":"2020-05-15","current":-17.536086,"twenty":-9.616954,"median":-0.000177,"eighty":-0.000177,"marketCap":2042673417},{"date":"2020-05-22","current":-20.877701,"twenty":-18.857355,"median":-10.428148,"eighty":-0.000177,"marketCap":2431918099},{"date":"2020-05-29","current":-22.436238,"twenty":-21.275146,"median":-17.743088,"eighty":-0.000177,"marketCap":2613462710},{"date":"2020-06-05","current":-21.221827,"twenty":-21.720306,"median":-19.727358,"eighty":-1.680174,"marketCap":2472003294},{"date":"2020-06-12","current":-24.48252,"twenty":-22.336656,"median":-21.221827,"eighty":-8.80576,"marketCap":2851821826},{"date":"2020-06-19","current":-25.199022,"twenty":-23.30697,"median":-21.389248,"eighty":-11.849736,"marketCap":2935282882},{"date":"2020-06-26","current":-26.200911,"twenty":-24.393868,"median":-21.768312,"eighty":-17.577486,"marketCap":3051986900},{"date":"2020-07-02","current":-30.997833,"twenty":-25.557273,"median":-22.254076,"eighty":-17.743088,"marketCap":3610751593},{"date":"2020-07-10","current":-26.352712,"twenty":-26.249487,"median":-22.440622,"eighty":-18.417326,"marketCap":3069669327},{"date":"2020-07-17","current":-29.753062,"twenty":-26.911341,"median":-23.432054,"eighty":-19.150707,"marketCap":3465755692},{"date":"2020-07-24","current":-29.54054,"twenty":-28.423282,"median":-24.078728,"eighty":-20.304008,"marketCap":3441000294},{"date":"2020-07-31","current":-28.235049,"twenty":-28.848326,"median":-24.48252,"eighty":-20.877701,"marketCap":3288931422},{"date":"2020-08-07","current":-29.224793,"twenty":-29.27337,"median":-25.642282,"eighty":-21.221827,"marketCap":3404220846},{"date":"2020-08-14","current":-24.002827,"twenty":-29.27337,"median":-25.727291,"eighty":-21.246115,"marketCap":2795945357},{"date":"2020-08-21","current":-12.705361,"twenty":-29.224793,"median":-25.378147,"eighty":-20.304008,"marketCap":3006838027},{"date":"2020-08-28","current":-13.700395,"twenty":-28.848326,"median":-24.470376,"eighty":-17.536086,"marketCap":3242321814},{"date":"2020-09-04","current":-11.038006,"twenty":-28.836182,"median":-24.036223,"eighty":-13.180467,"marketCap":2612243572},{"date":"2020-09-11","current":-11.557934,"twenty":-28.598157,"median":-23.596,"eighty":-12.625878,"marketCap":2735289155},{"date":"2020-09-18","current":-13.595812,"twenty":-28.456072,"median":-22.806633,"eighty":-12.292407,"marketCap":3217571266},{"date":"2020-09-25","current":-10.88536,"twenty":-28.425711,"median":-22.396769,"eighty":-12.012124,"marketCap":2576118310},{"date":"2020-10-02","current":-10.454224,"twenty":-28.389279,"median":-21.99905,"eighty":-11.634429,"marketCap":2474086227},{"date":"2020-10-09","current":-10.969642,"twenty":-28.264195,"median":-21.466135,"eighty":-11.291396,"marketCap":2596064431},{"date":"2020-10-16","current":-9.094467,"twenty":-27.963021,"median":-21.246115,"eighty":-10.880822,"marketCap":2152287575},{"date":"2020-10-23","current":-9.022315,"twenty":-27.501544,"median":-20.590854,"eighty":-10.812747,"marketCap":2135212088},{"date":"2020-10-30","current":-9.409314,"twenty":-27.155438,"median":-18.417326,"eighty":-10.696698,"marketCap":2226798793},{"date":"2020-11-06","current":-10.65886,"twenty":-26.947773,"median":-15.618241,"eighty":-10.523479,"marketCap":2522515190},{"date":"2020-11-13","current":-11.592266,"twenty":-26.464438,"median":-13.595812,"eighty":-10.632323,"marketCap":2615748437},{"date":"2020-11-20","current":-12.331832,"twenty":-26.308994,"median":-13.328378,"eighty":-10.658129,"marketCap":2782628530},{"date":"2020-11-27","current":-11.867453,"twenty":-26.276204,"median":-13.174491,"eighty":-10.680006,"marketCap":2677843356},{"date":"2020-12-04","current":-12.331832,"twenty":-26.254345,"median":-13.078277,"eighty":-10.696049,"marketCap":2782628530},{"date":"2020-12-11","current":-11.833055,"twenty":-26.220341,"median":-12.769705,"eighty":-10.707707,"marketCap":2670081491},{"date":"2020-12-18","current":-11.526909,"twenty":-26.146262,"median":-12.441907,"eighty":-10.723985,"marketCap":2601000894},{"date":"2020-12-24","current":-12.723974,"twenty":-26.100115,"median":-12.441907,"eighty":-10.751747,"marketCap":2871113789},{"date":"2020-12-31","current":-11.010933,"twenty":-26.055182,"median":-12.331832,"eighty":-10.788727,"marketCap":2484572922},{"date":"2021-01-08","current":-11.241402,"twenty":-25.89245,"median":-12.30097,"eighty":-10.74099,"marketCap":2536577416},{"date":"2021-01-15","current":-11.193244,"twenty":-25.71879,"median":-12.256155,"eighty":-10.74099,"marketCap":2525710805},{"date":"2021-01-22","current":-11.475311,"twenty":-25.684786,"median":-12.230255,"eighty":-10.784019,"marketCap":2589358097},{"date":"2021-01-29","current":-9.827627,"twenty":-25.557273,"median":-12.085078,"eighty":-10.730233,"marketCap":2217564773},{"date":"2021-02-05","current":-10.42272,"twenty":-25.199022,"median":-11.925931,"eighty":-10.694104,"marketCap":2351845034},{"date":"2021-02-12","current":-10.481197,"twenty":-24.48252,"median":-11.865086,"eighty":-10.540793,"marketCap":2365040204},{"date":"2021-02-19","current":-10.64287,"twenty":-24.472805,"median":-11.822736,"eighty":-10.545402,"marketCap":2401520969},{"date":"2021-02-26","current":-9.146539,"twenty":-24.164344,"median":-11.760818,"eighty":-10.475802,"marketCap":2063879850},{"date":"2021-03-05","current":-7.825639,"twenty":-24.073263,"median":-11.697181,"eighty":-10.427062,"marketCap":1765824242},{"date":"2021-03-12","current":-8.695919,"twenty":-24.016186,"median":-11.650743,"eighty":-10.337412,"marketCap":1962199421},{"date":"2021-03-19","current":-8.744074,"twenty":-23.793949,"median":-11.595706,"eighty":-10.111427,"marketCap":2153578034},{"date":"2021-03-26","current":-7.822006,"twenty":-23.508563,"median":-11.557934,"eighty":-9.980357,"marketCap":1926481811},{"date":"2021-04-01","current":-7.949725,"twenty":-23.439341,"median":-11.526909,"eighty":-9.766398,"marketCap":1957937707},{"date":"2021-04-09","current":-7.473115,"twenty":-23.056801,"median":-11.42698,"eighty":-9.494543,"marketCap":1840553511},{"date":"2021-04-16","current":-7.255058,"twenty":-22.589657,"median":-11.354744,"eighty":-9.404647,"marketCap":1786848323},{"date":"2021-04-23","current":-7.242598,"twenty":-22.439746,"median":-11.265481,"eighty":-9.176298,"marketCap":1783779455},{"date":"2021-04-30","current":-7.644445,"twenty":-22.388876,"median":-11.193244,"eighty":-9.059703,"marketCap":1882750444},{"date":"2021-05-07","current":-7.115899,"twenty":-22.295366,"median":-11.122033,"eighty":-8.882034,"marketCap":1809864832},{"date":"2021-05-14","current":-6.404007,"twenty":-22.10106,"median":-11.041891,"eighty":-8.724812,"marketCap":1628801627},{"date":"2021-05-21","current":-6.316529,"twenty":-21.860607,"median":-11.022972,"eighty":-8.581029,"marketCap":1606552335},{"date":"2021-05-28","current":-6.5307,"twenty":-21.624293,"median":-10.969642,"eighty":-8.364032,"marketCap":1661024740},{"date":"2021-06-04","current":-6.636713,"twenty":-21.478564,"median":-10.921497,"eighty":-8.204539,"marketCap":1687988214},{"date":"2021-06-11","current":-6.700063,"twenty":-21.392196,"median":-10.87763,"eighty":-8.015142,"marketCap":1704100828},{"date":"2021-06-18","current":-7.013799,"twenty":-21.32315,"median":-10.862668,"eighty":-7.846615,"marketCap":1783896635},{"date":"2021-06-25","current":-7.565853,"twenty":-21.2364,"median":-10.855893,"eighty":-7.68058,"marketCap":1924306563},{"date":"2021-07-02","current":-7.294351,"twenty":-21.084177,"median":-10.814044,"eighty":-7.589619,"marketCap":1855252500},{"date":"2021-07-09","current":-7.378818,"twenty":-20.762962,"median":-10.807561,"eighty":-7.53213,"marketCap":1876735987},{"date":"2021-07-16","current":-6.862965,"twenty":-20.073348,"median":-10.722423,"eighty":-7.453029,"marketCap":1745533266},{"date":"2021-07-23","current":-6.500962,"twenty":-19.004031,"median":-10.694467,"eighty":-7.384851,"marketCap":1653461182},{"date":"2021-07-30","current":-6.347111,"twenty":-18.282478,"median":-10.661185,"eighty":-7.309434,"marketCap":1614330546},{"date":"2021-08-06","current":-9.872651,"twenty":-17.701688,"median":-10.64287,"eighty":-7.309434,"marketCap":1978015279},{"date":"2021-08-13","current":-10.255609,"twenty":-16.768948,"median":-10.543674,"eighty":-7.346842,"marketCap":2054742016},{"date":"2021-08-20","current":-9.669684,"twenty":-13.693224,"median":-10.481197,"eighty":-7.352283,"marketCap":1937350109},{"date":"2021-08-27","current":-11.293424,"twenty":-13.650793,"median":-10.46771,"eighty":-7.359556,"marketCap":2262671474},{"date":"2021-09-03","current":-10.70367,"twenty":-13.580872,"median":-10.540793,"eighty":-7.384851,"marketCap":2144512299},{"date":"2021-09-10","current":-10.251779,"twenty":-13.52111,"median":-10.481197,"eighty":-7.408985,"marketCap":2053974749},{"date":"2021-09-17","current":-11.052161,"twenty":-13.45836,"median":-10.46771,"eighty":-7.435734,"marketCap":2214333629},{"date":"2021-09-24","current":-10.833875,"twenty":-13.198396,"median":-10.540793,"eighty":-7.438849,"marketCap":2170599389},{"date":"2021-10-01","current":-10.110085,"twenty":-13.180467,"median":-10.524755,"eighty":-7.448202,"marketCap":2025585856},{"date":"2021-10-08","current":-9.026315,"twenty":-13.168515,"median":-10.454224,"eighty":-7.472335,"marketCap":1808449191},{"date":"2021-10-15","current":-9.753934,"twenty":-13.135646,"median":-10.436428,"eighty":-7.473115,"marketCap":1954229991},{"date":"2021-10-22","current":-10.002857,"twenty":-13.078277,"median":-10.42794,"eighty":-7.481386,"marketCap":2004102370},{"date":"2021-10-29","current":-11.101946,"twenty":-13.061078,"median":-10.428044,"eighty":-7.526636,"marketCap":2224308105},{"date":"2021-11-05","current":-8.978957,"twenty":-12.834049,"median":-10.42272,"eighty":-7.554108,"marketCap":2258872162},{"date":"2021-11-12","current":-8.072824,"twenty":-12.723974,"median":-10.414231,"eighty":-7.565853,"marketCap":2030912586},{"date":"2021-11-19","current":-6.968379,"twenty":-12.705361,"median":-10.401133,"eighty":-7.554108,"marketCap":1753062867},{"date":"2021-11-26","current":-6.773118,"twenty":-12.69819,"median":-10.353923,"eighty":-7.479732,"marketCap":1703940265},{"date":"2021-12-03","current":-6.547347,"twenty":-12.583617,"median":-10.339859,"eighty":-7.438226,"marketCap":1647142256},{"date":"2021-12-10","current":-6.211742,"twenty":-12.46461,"median":-10.324541,"eighty":-7.354126,"marketCap":1562712783},{"date":"2021-12-17","current":-6.071398,"twenty":-12.395125,"median":-10.267318,"eighty":-7.293144,"marketCap":1527405913},{"date":"2021-12-23","current":-6.486328,"twenty":-12.352471,"median":-10.253694,"eighty":-7.250074,"marketCap":1631791443},{"date":"2021-12-31","current":-6.162927,"twenty":-12.331832,"median":-10.171358,"eighty":-7.105523,"marketCap":1550432133},{"date":"2022-01-07","current":-6.040889,"twenty":-12.3175,"median":-10.121011,"eighty":-7.020244,"marketCap":1519730506},{"date":"2022-01-14","current":-5.253743,"twenty":-12.299574,"median":-10.110085,"eighty":-6.950448,"marketCap":1321705016},{"date":"2022-01-21","current":-4.780845,"twenty":-12.287114,"median":-10.104599,"eighty":-6.910115,"marketCap":1202736214},{"date":"2022-01-28","current":-4.561176,"twenty":-12.268538,"median":-10.039178,"eighty":-6.845427,"marketCap":1147473286},{"date":"2022-02-04","current":-4.921189,"twenty":-12.253403,"median":-9.999027,"eighty":-6.800821,"marketCap":1238043084},{"date":"2022-02-11","current":-4.664908,"twenty":-12.241668,"median":-9.853579,"eighty":-6.776298,"marketCap":1173569669},{"date":"2022-02-18","current":-4.63745,"twenty":-12.20396,"median":-9.827627,"eighty":-6.705493,"marketCap":1166661803},{"date":"2022-02-25","current":-5.165265,"twenty":-12.16083,"median":-9.796669,"eighty":-6.699929,"marketCap":1299446337},{"date":"2022-03-04","current":-4.698153,"twenty":-12.130264,"median":-9.752019,"eighty":-6.643297,"marketCap":1080697249},{"date":"2022-03-11","current":-4.678132,"twenty":-12.058414,"median":-9.720992,"eighty":-6.550137,"marketCap":1076092005},{"date":"2022-03-18","current":-4.758372,"twenty":-12.012124,"median":-9.665854,"eighty":-6.518116,"marketCap":1094549297},{"date":"2022-03-25","current":-4.444486,"twenty":-11.956638,"median":-9.585433,"eighty":-6.483887,"marketCap":1022347448},{"date":"2022-04-01","current":-4.952046,"twenty":-11.921655,"median":-9.540274,"eighty":-6.413783,"marketCap":1139099373},{"date":"2022-04-08","current":-4.621465,"twenty":-11.897133,"median":-9.469884,"eighty":-6.348106,"marketCap":1063057001},{"date":"2022-04-14","current":-4.738337,"twenty":-11.867453,"median":-9.451949,"eighty":-6.33378,"marketCap":1089940668},{"date":"2022-04-22","current":-4.22076,"twenty":-11.862719,"median":-9.396921,"eighty":-6.301447,"marketCap":970884429},{"date":"2022-04-29","current":-3.930248,"twenty":-11.833055,"median":-9.359488,"eighty":-6.223946,"marketCap":904059314},{"date":"2022-05-06","current":-3.656433,"twenty":-11.812416,"median":-9.256858,"eighty":-6.181232,"marketCap":841074723},{"date":"2022-05-13","current":-2.908534,"twenty":-11.778017,"median":-9.146539,"eighty":-6.147606,"marketCap":567629425},{"date":"2022-05-20","current":-2.774717,"twenty":-11.760818,"median":-9.106345,"eighty":-6.098857,"marketCap":541513862},{"date":"2022-05-27","current":-2.908534,"twenty":-11.750499,"median":-9.084629,"eighty":-6.040889,"marketCap":567629425},{"date":"2022-06-03","current":-2.833754,"twenty":-11.720228,"median":-9.022315,"eighty":-5.907257,"marketCap":553035434},{"date":"2022-06-10","current":-2.625158,"twenty":-11.687894,"median":-8.959641,"eighty":-5.295236,"marketCap":512325881},{"date":"2022-06-17","current":-2.499214,"twenty":-11.659183,"median":-8.930575,"eighty":-5.114619,"marketCap":487746528},{"date":"2022-06-24","current":-3.105322,"twenty":-11.651867,"median":-8.88457,"eighty":-5.035294,"marketCap":606034663},{"date":"2022-07-01","current":-3.361147,"twenty":-11.644552,"median":-8.853868,"eighty":-4.979156,"marketCap":655961473},{"date":"2022-07-08","current":-4.057778,"twenty":-11.623913,"median":-8.75365,"eighty":-4.940669,"marketCap":791916017},{"date":"2022-07-15","current":-3.187973,"twenty":-11.596394,"median":-8.716575,"eighty":-4.916514,"marketCap":622164863},{"date":"2022-07-22","current":-2.896726,"twenty":-11.592266,"median":-8.673367,"eighty":-4.863223,"marketCap":565325110},{"date":"2022-07-29","current":-2.916405,"twenty":-11.578533,"median":-8.603044,"eighty":-4.834506,"marketCap":569165634},{"date":"2022-08-05","current":-3.266689,"twenty":-11.556014,"median":-8.464639,"eighty":-4.783286,"marketCap":637526959},{"date":"2022-08-12","current":-4.23153,"twenty":-11.542643,"median":-8.395183,"eighty":-4.759708,"marketCap":791147913},{"date":"2022-08-19","current":-3.459173,"twenty":-11.525533,"median":-8.255681,"eighty":-4.732722,"marketCap":646744216},{"date":"2022-08-26","current":-2.929204,"twenty":-11.509575,"median":-8.173063,"eighty":-4.684434,"marketCap":547658701},{"date":"2022-09-02","current":-2.641625,"twenty":-11.483364,"median":-8.056523,"eighty":-4.669511,"marketCap":493891367},{"date":"2022-09-09","current":-2.6379,"twenty":-11.455979,"median":-8.007179,"eighty":-4.639426,"marketCap":493194896},{"date":"2022-09-16","current":-2.244566,"twenty":-11.377028,"median":-7.912344,"eighty":-4.562396,"marketCap":419655300},{"date":"2022-09-23","current":-2.090653,"twenty":-11.370438,"median":-7.851859,"eighty":-4.517953,"marketCap":390878937},{"date":"2022-09-30","current":-2.060725,"twenty":-11.366962,"median":-7.79397,"eighty":-4.436472,"marketCap":385283533},{"date":"2022-10-07","current":-2.035073,"twenty":-11.354091,"median":-7.644366,"eighty":-4.262834,"marketCap":380487472},{"date":"2022-10-14","current":-2.009421,"twenty":-11.339866,"median":-7.603949,"eighty":-4.11858,"marketCap":375691412},{"date":"2022-10-21","current":-2.043624,"twenty":-11.292651,"median":-7.573998,"eighty":-3.940266,"marketCap":382086159},{"date":"2022-10-28","current":-1.958117,"twenty":-11.279928,"median":-7.526636,"eighty":-3.826688,"marketCap":366099290},{"date":"2022-11-04","current":-1.808479,"twenty":-11.239552,"median":-7.477251,"eighty":-3.665858,"marketCap":338122270},{"date":"2022-11-11","current":-1.973997,"twenty":-11.231385,"median":-7.448202,"eighty":-3.589422,"marketCap":327730806},{"date":"2022-11-18","current":-1.887333,"twenty":-11.222682,"median":-7.42236,"eighty":-3.46397,"marketCap":313342624},{"date":"2022-11-25","current":-1.728451,"twenty":-11.200124,"median":-7.366779,"eighty":-3.315383,"marketCap":286964291},{"date":"2022-12-02","current":-1.742895,"twenty":-11.193244,"median":-7.345635,"eighty":-3.187973,"marketCap":289362321},{"date":"2022-12-09","current":-1.492534,"twenty":-11.176045,"median":-7.291334,"eighty":-3.134618,"marketCap":247796463},{"date":"2022-12-16","current":-1.564753,"twenty":-11.170878,"median":-7.255058,"eighty":-3.093515,"marketCap":259786614},{"date":"2022-12-23","current":-1.694748,"twenty":-11.160897,"median":-7.17358,"eighty":-3.058093,"marketCap":281368887},{"date":"2022-12-30","current":-1.848816,"twenty":-11.116799,"median":-7.102928,"eighty":-3.00812,"marketCap":306947877},{"date":"2023-01-06","current":-1.709192,"twenty":-11.103478,"median":-7.054747,"eighty":-2.977803,"marketCap":283766917},{"date":"2023-01-13","current":-2.407313,"twenty":-11.09068,"median":-7.013799,"eighty":-2.914951,"marketCap":399671715},{"date":"2023-01-20","current":-2.262874,"twenty":-11.070766,"median":-6.968379,"eighty":-2.901449,"marketCap":375691412},{"date":"2023-01-27","current":-2.431386,"twenty":-11.048053,"median":-6.93989,"eighty":-2.850284,"marketCap":403668432},{"date":"2023-02-03","current":-2.248921,"twenty":-11.041891,"median":-6.907359,"eighty":-2.831392,"marketCap":373374900},{"date":"2023-02-10","current":-2.137204,"twenty":-11.040337,"median":-6.853562,"eighty":-2.793261,"marketCap":354827118},{"date":"2023-02-17","current":-2.112917,"twenty":-11.037541,"median":-6.82206,"eighty":-2.774717,"marketCap":350794992},{"date":"2023-02-24","current":-1.942913,"twenty":-11.036477,"median":-6.802631,"eighty":-2.759761,"marketCap":322570108},{"date":"2023-03-03","current":-1.625273,"twenty":-11.030196,"median":-6.790993,"eighty":-2.711745,"marketCap":253217534},{"date":"2023-03-10","current":-1.420669,"twenty":-11.009222,"median":-6.773118,"eighty":-2.662154,"marketCap":221340216},{"date":"2023-03-17","current":-1.161423,"twenty":-11.000648,"median":-6.710401,"eighty":-2.626851,"marketCap":180949666},{"date":"2023-03-24","current":-0.995505,"twenty":-10.988916,"median":-6.70308,"eighty":-2.577952,"marketCap":155099713},{"date":"2023-03-31","current":-1.01106,"twenty":-10.962077,"median":-6.692438,"eighty":-2.500092,"marketCap":157523146},{"date":"2023-04-06","current":-1.062909,"twenty":-10.931816,"median":-6.657557,"eighty":-2.436957,"marketCap":165601257},{"date":"2023-04-14","current":-1.223642,"twenty":-10.921497,"median":-6.636713,"eighty":-2.398479,"marketCap":190643398},{"date":"2023-04-21","current":-1.156238,"twenty":-10.914296,"median":-6.554322,"eighty":-2.368796,"marketCap":180141855},{"date":"2023-04-28","current":-1.005875,"twenty":-10.904834,"median":-6.5307,"eighty":-2.325798,"marketCap":156715335},{"date":"2023-05-05","current":-1.005875,"twenty":-10.88536,"median":-6.511651,"eighty":-2.272503,"marketCap":156715335},{"date":"2023-05-12","current":-0.980447,"twenty":-10.869899,"median":-6.486328,"eighty":-2.248921,"marketCap":194682453},{"date":"2023-05-19","current":-1.053675,"twenty":-10.869899,"median":-6.450763,"eighty":-2.200348,"marketCap":209223051},{"date":"2023-05-26","current":-0.939765,"twenty":-10.862668,"median":-6.413105,"eighty":-2.159059,"marketCap":186604343},{"date":"2023-06-02","current":-0.968242,"twenty":-10.860198,"median":-6.392361,"eighty":-2.148819,"marketCap":192259020},{"date":"2023-06-09","current":-1.017061,"twenty":-10.859458,"median":-6.347111,"eighty":-2.134413,"marketCap":201952752},{"date":"2023-06-16","current":-0.939765,"twenty":-10.853773,"median":-6.33378,"eighty":-2.098346,"marketCap":186604343},{"date":"2023-06-23","current":-0.870604,"twenty":-10.841269,"median":-6.306322,"eighty":-2.090211,"marketCap":172871556},{"date":"2023-06-30","current":-0.878741,"twenty":-10.831773,"median":-6.301447,"eighty":-2.062435,"marketCap":174487178},{"date":"2023-07-07","current":-0.8584,"twenty":-10.828621,"median":-6.247355,"eighty":-2.059487,"marketCap":170448123},{"date":"2023-07-14","current":-0.630578,"twenty":-10.818557,"median":-6.223946,"eighty":-2.035073,"marketCap":125210706},{"date":"2023-07-21","current":-0.610237,"twenty":-10.814044,"median":-6.202589,"eighty":-2.002884,"marketCap":121171651},{"date":"2023-07-28","current":-0.504462,"twenty":-10.811422,"median":-6.177771,"eighty":-1.988044,"marketCap":100168565},{"date":"2023-08-04","current":-0.606168,"twenty":-10.808333,"median":-6.162927,"eighty":-1.965383,"marketCap":120363840},{"date":"2023-08-11","current":-0.717329,"twenty":-10.788727,"median":-6.115637,"eighty":-1.932105,"marketCap":130057572},{"date":"2023-08-18","current":-0.619309,"twenty":-10.777949,"median":-6.098857,"eighty":-1.908523,"marketCap":112285730},{"date":"2023-08-25","current":-0.614854,"twenty":-10.739473,"median":-6.068347,"eighty":-1.867341,"marketCap":111477919},{"date":"2023-09-01","current":-0.534656,"twenty":-10.727364,"median":-6.007328,"eighty":-1.832253,"marketCap":96937321},{"date":"2023-09-08","current":-0.485645,"twenty":-10.725115,"median":-5.944784,"eighty":-1.81759,"marketCap":88051400},{"date":"2023-09-15","current":-0.388962,"twenty":-10.721176,"median":-5.839526,"eighty":-1.773708,"marketCap":70521901},{"date":"2023-09-22","current":-0.324803,"twenty":-10.712425,"median":-5.305609,"eighty":-1.751033,"marketCap":58889422},{"date":"2023-09-29","current":-0.369803,"twenty":-10.702405,"median":-5.16679,"eighty":-1.729414,"marketCap":67048313},{"date":"2023-10-06","current":-0.38317,"twenty":-10.697346,"median":-5.107297,"eighty":-1.694748,"marketCap":69471746},{"date":"2023-10-13","current":-0.373145,"twenty":-10.694467,"median":-5.05238,"eighty":-1.67549,"marketCap":67654172},{"date":"2023-10-20","current":-0.345744,"twenty":-10.694104,"median":-5.001468,"eighty":-1.636973,"marketCap":62686134},{"date":"2023-10-27","current":-0.291788,"twenty":-10.681866,"median":-4.994411,"eighty":-1.626101,"marketCap":52903543},{"date":"2023-11-03","current":-0.311927,"twenty":-10.661649,"median":-4.952046,"eighty":-1.553198,"marketCap":56554848},{"date":"2023-11-10","current":-0.211833,"twenty":-10.658129,"median":-4.93535,"eighty":-1.49579,"marketCap":37813633},{"date":"2023-11-17","current":-0.287769,"twenty":-10.652738,"median":-4.919922,"eighty":-1.466535,"marketCap":51368702},{"date":"2023-11-24","current":-0.33352,"twenty":-10.64287,"median":-4.910192,"eighty":-1.446594,"marketCap":59535671},{"date":"2023-12-01","current":-0.375606,"twenty":-10.630908,"median":-4.885262,"eighty":-1.31697,"marketCap":67048313},{"date":"2023-12-08","current":-0.484215,"twenty":-10.549994,"median":-4.844915,"eighty":-1.223642,"marketCap":86435778},{"date":"2023-12-13","current":-0.466114,"twenty":-10.54793,"median":-4.838513,"eighty":-1.195643,"marketCap":83204534},{"date":"2023-12-20","current":-0.610926,"twenty":-10.546554,"median":-4.831835,"eighty":-1.192532,"marketCap":109054486},{"date":"2023-12-29","current":-0.719535,"twenty":-10.54425,"median":-4.805252,"eighty":-1.158312,"marketCap":128441950},{"date":"2024-01-05","current":-0.85077,"twenty":-10.540793,"median":-4.794574,"eighty":-1.119943,"marketCap":151868469},{"date":"2024-01-12","current":-0.936753,"twenty":-10.508716,"median":-4.768224,"eighty":-1.078085,"marketCap":167216879},{"date":"2024-01-19","current":-0.828144,"twenty":-10.486701,"median":-4.761711,"eighty":-1.062909,"marketCap":147829414},{"date":"2024-01-26","current":-1.172072,"twenty":-10.459619,"median":-4.750335,"eighty":-1.05774,"marketCap":209223051},{"date":"2024-02-02","current":-1.629135,"twenty":-10.445532,"median":-4.728978,"eighty":-1.061876,"marketCap":290811963},{"date":"2024-02-09","current":-1.778472,"twenty":-10.443278,"median":-4.692209,"eighty":-1.062909,"marketCap":317469726},{"date":"2024-02-16","current":-2.249111,"twenty":-10.432331,"median":-4.678231,"eighty":-1.062909,"marketCap":401482071},{"date":"2024-02-23","current":-2.212908,"twenty":-10.428728,"median":-4.671459,"eighty":-1.06602,"marketCap":395019583},{"date":"2024-03-01","current":-2.185756,"twenty":-10.428023,"median":-4.654836,"eighty":-1.071205,"marketCap":390172717},{"date":"2024-03-08","current":-2.249111,"twenty":-10.424808,"median":-4.63745,"eighty":-1.076163,"marketCap":401482071},{"date":"2024-03-15","current":-1.285802,"twenty":-10.422173,"median":-4.564227,"eighty":-1.078085,"marketCap":308660513},{"date":"2024-03-22","current":-1.584905,"twenty":-10.418227,"median":-4.534645,"eighty":-1.080526,"marketCap":380461220},{"date":"2024-03-28","current":-1.443948,"twenty":-10.414553,"median":-4.517949,"eighty":-1.084825,"marketCap":346624105},{"date":"2024-04-05","current":-1.619285,"twenty":-10.41109,"median":-4.460118,"eighty":-1.101278,"marketCap":388714175},{"date":"2024-04-12","current":-1.608971,"twenty":-10.405728,"median":-4.414434,"eighty":-1.124091,"marketCap":386238289},{"date":"2024-04-19","current":-1.636475,"twenty":-10.398069,"median":-4.295892,"eighty":-1.140683,"marketCap":392840653},{"date":"2024-04-26","current":-1.52646,"twenty":-10.377654,"median":-4.22076,"eighty":-1.158312,"marketCap":366431197},{"date":"2024-05-03","current":-1.631766,"twenty":-10.352893,"median":-4.075824,"eighty":-1.165683,"marketCap":391710220},{"date":"2024-05-10","current":-1.934067,"twenty":-10.348284,"median":-3.980337,"eighty":-1.180256,"marketCap":439584360},{"date":"2024-05-17","current":-1.730926,"twenty":-10.340625,"median":-3.906874,"eighty":-1.192532,"marketCap":393413574},{"date":"2024-05-24","current":-1.541071,"twenty":-10.334498,"median":-3.812485,"eighty":-1.194606,"marketCap":350262319},{"date":"2024-05-31","current":-1.456397,"twenty":-10.330668,"median":-3.709778,"eighty":-1.199791,"marketCap":331017137},{"date":"2024-06-07","current":-1.473332,"twenty":-10.31535,"median":-3.648185,"eighty":-1.208125,"marketCap":334866173},{"date":"2024-06-14","current":-1.337853,"twenty":-10.278586,"median":-3.606118,"eighty":-1.208275,"marketCap":304073881},{"date":"2024-06-21","current":-1.138868,"twenty":-10.272811,"median":-3.552032,"eighty":-1.196955,"marketCap":258847703},{"date":"2024-06-28","current":-1.189673,"twenty":-10.269747,"median":-3.518578,"eighty":-1.194669,"marketCap":270394812},{"date":"2024-07-05","current":-1.295516,"twenty":-10.263268,"median":-3.471164,"eighty":-1.197717,"marketCap":294451290},{"date":"2024-07-12","current":-1.604577,"twenty":-10.255609,"median":-3.335924,"eighty":-1.208087,"marketCap":364696206},{"date":"2024-07-15","current":-1.617278,"twenty":-10.254843,"median":-3.325654,"eighty":-1.208125,"marketCap":367582983},{"date":"2024-08-02","current":-1.295516,"twenty":-10.254077,"median":-3.315383,"eighty":-1.208162,"marketCap":294451290},{"date":"2024-08-09","current":-1.263706,"twenty":-10.233994,"median":-3.270494,"eighty":-1.210995,"marketCap":271579334},{"date":"2024-08-16","current":-1.317672,"twenty":-10.192933,"median":-3.17981,"eighty":-1.208162,"marketCap":283177028},{"date":"2024-08-23","current":-1.268203,"twenty":-10.162167,"median":-3.145552,"eighty":-1.210995,"marketCap":272545809},{"date":"2024-08-30","current":-1.290689,"twenty":-10.138739,"median":-3.105322,"eighty":-1.216769,"marketCap":277378181},{"date":"2024-09-06","current":-1.272701,"twenty":-10.12297,"median":-3.093515,"eighty":-1.220176,"marketCap":273512283},{"date":"2024-09-13","current":-1.32217,"twenty":-10.116822,"median":-3.065371,"eighty":-1.220176,"marketCap":284143503},{"date":"2024-09-20","current":-1.443593,"twenty":-10.112524,"median":-3.046286,"eighty":-1.224459,"marketCap":310238314},{"date":"2024-09-27","current":-1.349715,"twenty":-10.110085,"median":-3.003246,"eighty":-1.228628,"marketCap":290063127},{"date":"2024-10-04","current":-1.37221,"twenty":-10.110085,"median":-2.991185,"eighty":-1.247882,"marketCap":294897512},{"date":"2024-10-11","current":-1.232739,"twenty":-10.108988,"median":-2.979377,"eighty":-1.25472,"marketCap":264924322},{"date":"2024-10-18","current":-1.412701,"twenty":-10.098738,"median":-2.942483,"eighty":-1.256542,"marketCap":303599406},{"date":"2024-10-25","current":-1.300225,"twenty":-10.072544,"median":-2.912771,"eighty":-1.264605,"marketCap":279427479},{"date":"2024-10-31","current":-1.327219,"twenty":-10.061536,"median":-2.908534,"eighty":-1.268203,"marketCap":285228741},{"date":"2024-11-08","current":-1.342191,"twenty":-10.016819,"median":-2.877047,"eighty":-1.272701,"marketCap":283294987},{"date":"2024-11-15","current":-1.207766,"twenty":-10.002857,"median":-2.845561,"eighty":-1.272701,"marketCap":256227485},{"date":"2024-11-22","current":-0.884176,"twenty":-9.999027,"median":-2.833754,"eighty":-1.254712,"marketCap":187577856},{"date":"2024-11-29","current":-1.102941,"twenty":-9.922436,"median":-2.823914,"eighty":-1.235926,"marketCap":233988873},{"date":"2024-12-06","current":-0.87506,"twenty":-9.878778,"median":-2.801848,"eighty":-1.222775,"marketCap":185644064},{"date":"2024-12-13","current":-0.902406,"twenty":-9.842136,"median":-2.782034,"eighty":-1.218462,"marketCap":191445441},{"date":"2024-12-20","current":-0.966213,"twenty":-9.834385,"median":-2.774717,"eighty":-1.208023,"marketCap":204981988},{"date":"2024-12-27","current":-0.966213,"twenty":-9.830318,"median":-2.76291,"eighty":-1.195312,"marketCap":204981988},{"date":"2025-01-03","current":-0.911521,"twenty":-9.816532,"median":-2.755039,"eighty":-1.190817,"marketCap":193379234},{"date":"2025-01-10","current":-0.87506,"twenty":-9.799245,"median":-2.727488,"eighty":-1.162092,"marketCap":185644064},{"date":"2025-01-17","current":-0.797581,"twenty":-9.795781,"median":-2.68813,"eighty":-1.132024,"marketCap":169206829},{"date":"2025-01-24","current":-0.802139,"twenty":-9.79223,"median":-2.664516,"eighty":-1.102941,"marketCap":170173725},{"date":"2025-01-31","current":-0.783908,"twenty":-9.753934,"median":-2.6379,"eighty":-1.078085,"marketCap":166306141},{"date":"2025-02-07","current":-0.738332,"twenty":-9.750105,"median":-2.624564,"eighty":-1.062909,"marketCap":156637179},{"date":"2025-02-14","current":-0.733775,"twenty":-9.727127,"median":-2.578044,"eighty":-1.057724,"marketCap":155670283},{"date":"2025-02-21","current":-0.76112,"twenty":-9.722219,"median":-2.565218,"eighty":-1.046317,"marketCap":161471660},{"date":"2025-02-28","current":-0.720102,"twenty":-9.701391,"median":-2.501409,"eighty":-1.037402,"marketCap":152769594},{"date":"2025-03-07","current":-0.797581,"twenty":-9.675045,"median":-2.460274,"eighty":-1.026615,"marketCap":169206829},{"date":"2025-03-14","current":-0.806696,"twenty":-9.663556,"median":-2.41935,"eighty":-1.016898,"marketCap":171140622},{"date":"2025-03-21","current":-0.774793,"twenty":-9.609408,"median":-2.398479,"eighty":-1.016245,"marketCap":164372348},{"date":"2025-03-28","current":-0.954142,"twenty":-9.587597,"median":-2.385077,"eighty":-1.011643,"marketCap":150607433},{"date":"2025-04-04","current":-0.772101,"twenty":-9.576242,"median":-2.368796,"eighty":-1.005875,"marketCap":121873120},{"date":"2025-04-11","current":-0.703052,"twenty":-9.567817,"median":-2.338996,"eighty":-0.992186,"marketCap":110973898},{"date":"2025-04-17","current":-0.728161,"twenty":-9.535072,"median":-2.32592,"eighty":-0.985973,"marketCap":114937252},{"date":"2025-04-21","current":-0.759547,"twenty":-9.524667,"median":-2.325798,"eighty":-0.984197,"marketCap":119891443}],"updateTime":1745321240593}}}